It seems pretty rare for companies to actively seek buyouts just to capture some discount on the present value of royalties. It's not as common as investors would like anyway.
It's also quite possible FRX looked at the Biolinerx project as well and must have passed. You'd think if it was actively shopped it would have made it's way to FRX.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.